 The potential for psychological dependence is similar to that of zolpidem.The drug was initially released November 2014 in Japan, then later reached the United States in February 2015, Australia in November 2016, and Canada in November 2018

Suvorexant is used for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.It is unclear how the medication compares to others used for insomnia as no comparisons have been done.